Trailblazer Amgen Scoops First US Stelara Biosimilar – With Interchangeability
California-Based Biotech Can Launch Wezlana On Or Before 1 January 2025
With its portfolio of biosimilars continuing to grow, Amgen has received the first approval in the US for a biosimilar to Stelara – weeks after Alvotech/Teva was hit with a complete response letter.
